Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to -$0.85.

  • HeartSciences' EPS (Weighted Average and Diluted) rose 6255.51% to -$0.85 in Q4 2025 from the same period last year, while for Oct 2025 it was -$6.88, marking a year-over-year increase of 1190.78%. This contributed to the annual value of -$9.44 for FY2025, which is 4964.99% up from last year.
  • HeartSciences' EPS (Weighted Average and Diluted) amounted to -$0.85 in Q4 2025, which was up 6255.51% from -$1.58 recorded in Q3 2025.
  • HeartSciences' 5-year EPS (Weighted Average and Diluted) high stood at $0.11 for Q2 2024, and its period low was -$79.36 during Q2 2023.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$6.98, with a median of -$1.22 in 2025.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 1290983.61% in 2023, then surged by 10013.86% in 2024.
  • Over the past 5 years, HeartSciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.31 in 2021, then grew by 29.03% to -$0.22 in 2022, then tumbled by 7136.36% to -$15.92 in 2023, then skyrocketed by 85.74% to -$2.27 in 2024, then skyrocketed by 62.56% to -$0.85 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.85 for Q4 2025, versus -$1.58 for Q3 2025 and -$2.24 for Q2 2025.